CRVO — CervoMed Cashflow Statement
0.000.00%
Last trade - 00:00- $35.46m
- $14.60m
- $4.01m
Annual cashflow statement for CervoMed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.1 | -15.6 | -2.17 | -16.3 | -27 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 9.59 | 0.719 | -5.02 | 0.201 | 0.284 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.356 | -0.097 | -0.261 | -0.441 | 3.23 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -14.5 | -15 | -7.45 | -16.5 | -23.4 |
| Other Investing Cash Flow Items | 0.004 | -12.2 | — | -28.7 | 18.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0.004 | -12.2 | — | -28.7 | 18.1 |
| Financing Cash Flow Items | 0 | — | 10.3 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 33.3 | 0.005 | 11.1 | 46.4 | 4.59 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18.8 | -27.2 | 3.7 | 1.21 | -0.764 |